These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28630120)

  • 1. Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.
    Machlus KR; Wu SK; Vijey P; Soussou TS; Liu ZJ; Shacham E; Unger TJ; Kashyap T; Klebanov B; Sola-Visner M; Crochiere M; Italiano JE; Landesman Y
    Blood; 2017 Aug; 130(9):1132-1143. PubMed ID: 28630120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
    Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
    Elife; 2021 Jun; 10():. PubMed ID: 34059198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.
    Kuruvilla J; Savona M; Baz R; Mau-Sorensen PM; Gabrail N; Garzon R; Stone R; Wang M; Savoie L; Martin P; Flinn I; Jacoby M; Unger TJ; Saint-Martin JR; Rashal T; Friedlander S; Carlson R; Kauffman M; Shacham S; Gutierrez M
    Blood; 2017 Jun; 129(24):3175-3183. PubMed ID: 28468797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
    Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
    Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.
    Pecci A
    Int J Hematol; 2013 Jul; 98(1):34-47. PubMed ID: 23636669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of platelet factor 4 in radiation-induced thrombocytopenia.
    Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet enhancement by Carica papaya L. leaf fractions in cyclophosphamide induced thrombocytopenic rats is due to elevated expression of CD110 receptor on megakaryocytes.
    Nandini C; Madhunapantula SV; Bovilla VR; Ali M; Mruthunjaya K; Santhepete MN; Jayashree K
    J Ethnopharmacol; 2021 Jul; 275():114074. PubMed ID: 33831466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
    Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
    Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
    Thein KZ; Piha-Paul SA; Tsimberidou A; Karp DD; Janku F; Zarifa A; Shah J; Milton DR; Bean S; McQuinn L; Gong J; Colen R; Carter BW; Subbiah V; Ogbonna DC; Pant S; Meric-Bernstam F; Naing A
    Invest New Drugs; 2021 Oct; 39(5):1357-1365. PubMed ID: 33909232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation.
    Di Buduo CA; Currao M; Pecci A; Kaplan DL; Balduini CL; Balduini A
    Haematologica; 2016 Dec; 101(12):1479-1488. PubMed ID: 27515246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKC-epsilon deficiency alters progenitor cell populations in favor of megakaryopoiesis.
    Kostyak JC; Liverani E; Kunapuli SP
    PLoS One; 2017; 12(8):e0182867. PubMed ID: 28783756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.
    Murai K; Kowata S; Shimoyama T; Yashima-Abo A; Fujishima Y; Ito S; Ishida Y
    Eur J Haematol; 2014 Oct; 93(4):290-6. PubMed ID: 24750292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia.
    Bishton MJ; Harrison SJ; Martin BP; McLaughlin N; James C; Josefsson EC; Henley KJ; Kile BT; Prince HM; Johnstone RW
    Blood; 2011 Mar; 117(13):3658-68. PubMed ID: 21292776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies.
    Li W; Morrone K; Kambhampati S; Will B; Steidl U; Verma A
    Leukemia; 2016 Mar; 30(3):536-44. PubMed ID: 26500138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials.
    Gavriatopoulou M; Chari A; Chen C; Bahlis N; Vogl DT; Jakubowiak A; Dingli D; Cornell RF; Hofmeister CC; Siegel D; Berdeja JG; Reece D; White D; Lentzsch S; Gasparetto C; Huff CA; Jagannath S; Baz R; Nooka AK; Richter J; Abonour R; Parker TL; Yee AJ; Moreau P; Lonial S; Tuchman S; Weisel KC; Mohty M; Choquet S; Unger TJ; Li K; Chai Y; Li L; Shah J; Shacham S; Kauffman MG; Dimopoulos MA
    Leukemia; 2020 Sep; 34(9):2430-2440. PubMed ID: 32094461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets.
    Liu HD; Zhang AJ; Xu JJ; Chen Y; Zhu YC
    J Hematol Oncol; 2016 Feb; 9():13. PubMed ID: 26912146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milestones in understanding platelet production: a historical overview.
    Kuter DJ
    Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia.
    Kanaji T; Vo MN; Kanaji S; Zarpellon A; Shapiro R; Morodomi Y; Yuzuriha A; Eto K; Belani R; Do MH; Yang XL; Ruggeri ZM; Schimmel P
    Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8228-E8235. PubMed ID: 30104364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the safety and efficacy of recombinant human thrombopoietin among severe sepsis patients with thrombocytopenia: study protocol for a randomized controlled trial.
    Wu Q; Ren J; Wang G; Gu G; Hu D; Liu S; Li G; Chen J; Li R; Hong Z; Ren H; Wu X; Li Y; Yao M; Zhao Y; Li J
    Trials; 2015 May; 16():220. PubMed ID: 25986785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.